Live Attenuated Influenza Vaccine As a Nasal Model for Influenza Infection

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Influenza

Interventions

DRUG

Flumist Quadrivalent Nasal Product

FLUMIST QUADRIVALENT 0.2 mL dose supplied in a single-dose pre-filled intranasal sprayer

Trial Locations (1)

RECRUITING

UAB Lung Health Center, Birmingham

All Listed Sponsors

lead

University of Alabama at Birmingham

OTHER